文献
J-GLOBAL ID:202102244871430547
整理番号:21A0451826
フィンゴリモドは血清中ケモカイン濃度を減少せずに多発性硬化症の再発を抑制する:フィンゴリモド中止後の再発の意味
Fingolimod can suppress multiple sclerosis relapses without decreasing serum chemokine levels: implications for relapses after fingolimod discontinuation
著者 (10件):
MIYAZAKI Yusei
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
NIINO Masaaki
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
TAKAHASHI Eri
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
FUKAZAWA Toshiyuki
(Sapporo Neurology Hospital, Hokkaido, JPN)
,
AMINO Itaru
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
NAKANO Fumihito
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
AKIMOTO Sachiko
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
MINAMI Naoya
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
DOI Shizuki
(NHO Hokkaido Medical Center, Hokkaido, JPN)
,
KIKUCHI Seiji
(NHO Hokkaido Medical Center, Hokkaido, JPN)
資料名:
Clinical and Experimental Neuroimmunology (Web)
(Clinical and Experimental Neuroimmunology (Web))
巻:
11 Suppl S1
ページ:
60
発行年:
2020年
JST資料番号:
U0510A
ISSN:
1759-1961
資料種別:
逐次刊行物 (A)
記事区分:
会議録記事
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)